Balo Andrew K
- SEC CIK
- 0001323190
No open-market purchases or sales filed in the past year.
Current role at each company
- GCTK Glucotrack, Inc.Directoras of Oct 7, 2025
- DXCM Dexcom IncEVP Regulatory Strategy Clinicas of Mar 14, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Balo Andrew K as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DXCM Dexcom Inc
EVP Regulatory Strategy Clinic3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2021 (view filing) | Sep 9 | 4 days | Balo Andrew K* | SSale | −5.60K | $546.78 | −$3.06M | −42.6%7.55K after | 10 lots |
| Aug 4, 2021 (view filing) | Aug 3 | 1 day | Balo Andrew K* | SSale | −2.76K | $515.87 | −$1.42M | −20.6%10.7K after | 8 lots |
| Jul 8, 2021 (view filing) | Jul 6 | 2 days | Balo Andrew K* | SSale | −2.97K | $430.14 | −$1.28M | −18.2%13.4K after | 4 lots |